Phenylalanine Requirement of Adults >65 Years.
NCT02971059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-09-18
Summary
Currently there are insufficient published studies on amino acid requirements in the elderly. Phenylalanine is one of the indispensable amino acids. Low levels of phenylalanine has been observed in in the blood of older adults. It is due the increased uptake by the liver and intestine. This decreased levels of phenylalanine could lead to decreased skeletal muscle protein synthesis. Requirement for elderly individuals have been set based on studies conducted in younger adults hence may be inaccurate. The goal of this study is to directly measure the phenylalanine requirement of male and female elderly subjects over 65 years using the direct amino acid oxidation (DAAO) technique.
Conditions
- Older Adults
Interventions
- DIETARY_SUPPLEMENT
-
Phenylalanine intake
Phenylalanine will be provided as graded intakes ranging from 7-40 mg/kg/day
Sponsors & Collaborators
-
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Glenda Courtney-Martin · Hospital for Sick Children, Toronto, Ontario
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Retinoic Acid Supplementation and Subjects With Hypercholesterolemia
NCT02497833 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of SNPs in the BCMO1 Enzyme
NCT02276014 ·Status: COMPLETED ·Phase: NA
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
NCT01653184 ·Status: COMPLETED ·Phase: NA
-
Carotenoid Supplementation and Normal Ocular Health
NCT02147171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860 ·Status: COMPLETED ·Phase: NA
-
Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).
NCT00987129 ·Status: TERMINATED
-
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
NCT00060749 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Alpha Lipoic Acid in Geographic Atrophy
NCT02613572 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DHA and X-Linked Retinitis Pigmentosa
NCT00100230 ·Status: COMPLETED ·Phase: PHASE2
-
Antioxidant Systems and Age-Related Macular Degeneration
NCT00668213 ·Status: COMPLETED
-
Omega-3-fatty Acids on Age-related Macular
NCT01258335 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605 ·Status: COMPLETED ·Phase: NA
-
Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
NCT00004345 ·Status: TERMINATED
-
"Visiobiane Anti-age" Effects on Vision Parameters
NCT00449917 ·Status: COMPLETED ·Phase: PHASE4
-
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
NCT02136303 ·Status: UNKNOWN ·Phase: NA
-
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
NCT03367767 ·Status: COMPLETED
-
Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease
NCT03297515 ·Status: COMPLETED ·Phase: NA
-
Role of Xanthophylls in Visual Function
NCT05794074 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation
NCT02264938 ·Status: COMPLETED ·Phase: NA
-
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
NCT03478865 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Eggs and Egg Products on Macular Pigment
NCT00527553 ·Status: COMPLETED ·Phase: NA
-
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL
NCT03574701 ·Status: UNKNOWN ·Phase: NA
-
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A
NCT00000116 ·Status: COMPLETED ·Phase: PHASE3